Ameriprise’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Ameriprise’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-48,631	Closed	-$850K	–	3938
2020 Q4	$850K	Sell	48,631 -15,100	-24%	-$212K	﹤0.01%	3159
2020 Q3	$745K	Buy	+63,731	New	+$846K	﹤0.01%	3091
2015 Q2	–	Sell	-34,245	Closed	-$482K	–	4098
2015 Q1	$482K	Sell	34,245 -13,700	-29%	-$186K	﹤0.01%	3217
2014 Q4	$653K	Hold	47,945	–	–	﹤0.01%	3022
2014 Q3	$732K	Hold	47,945	–	–	﹤0.01%	2920
2014 Q2	$807K	Buy	47,945 +19,645	+69%	+$354K	﹤0.01%	2843
2014 Q1	$568K	Buy	+28,300	New	+$612K	﹤0.01%	2916

Ameriprise's OXFD Position: Q1 2021 in Review

Ameriprise sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 48,631 shares — an estimated $850K sold.

Ameriprise first reported a position in OXFD in Q1 2014 and held it in 7 quarters. The position peaked at $850K in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Ameriprise reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Ameriprise sold 48,631 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $850K.
Ameriprise first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2014 and held it in 7 quarters.
Ameriprise's Oxford Immunotec Global PLC Ordinary Shares position peaked at $850K in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.